Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure nejmoa1902328 RETOUR MarcGuevreguian2021-03-23T10:51:35+01:00